Benserazide Hydrochloride |
|
Approved |
|
|
Mainland China |
Parkinson Disease; Dyskinesias |
Shanghai Yishengyuan Pharmaceutical Co Ltd |
1995-01-01 |
Dyskinesias; Parkinson Disease |
Details
|
Carbidopa |
MK-486 |
Approved |
|
Lodosyn |
Mainland China |
Parkinson Disease |
Nantong Jinghua Pharmaceutical Co Ltd |
1977-04-25 |
Postural Orthostatic Tachycardia Syndrome; Parkinson Disease; Orthostatic Intolerance |
Details
|
Carbidopa/Entacapone/Levodopa |
ODM-101; ELC-200 |
Approved |
Orion Pharma |
Trigel, LECIGel, 达灵复, Stalevo, LECIGon |
Japan |
Parkinson Disease |
Novartis Pharma Ag |
2003-06-11 |
Parkinson Disease |
Details
|
Levodopa/Carbidopa |
IPX-054; AP-09004; DM-1992; AP-CDLD; TPI-926; IPX-066; ABT-SLV-187; AP-CD/LD; ND-0612; ND-0680; ND-0612L; ND-0612H; PW-4153; LCIG; ABT-SLV187; IPX-203; CP-012; JM-012; SOL-707; INP-107(POD™ carbidopa/levodopa) |
Approved |
Merck Sharp & Dohme Corp |
Nacom (imciromab), Nacom retard, Parcopa, Patrome, DopaFuse, Sinemet, Numient, Menesit, Duodopa, Vadova, Rytary, Isicom, Duopa |
Mainland China |
Parkinson Disease |
Jinghua Pharmaceutical Group Co Ltd |
1975-05-02 |
Amblyopia; Amyotrophic Lateral Sclerosis; Diabetic Retinopathy; Diabetes Mellitus; Albinism; Cocaine-Related Disorders; Cognitive Dysfunction; Depressive Disorder, Treatment-Resistant; Albinism, Oculocutaneous; Gait Apraxia; Parkinson Disease; Aphasia, Broca; Stroke; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Depression; Motor Neuron Disease |
Details
|
Eladocagene exuparvovec |
PTC-AADC |
Approved |
National Taiwan University, Ptc Therapeutics Inc |
Upstaza |
United Kingdom |
Aromatic amino acid decarboxylase deficiency |
Ptc Therapeutics Inc |
2022-07-18 |
Aromatic amino acid decarboxylase deficiency; Amino Acid Metabolism, Inborn Errors |
Details
|
Carbidopa/Melevodopa |
V-1512; GT-1512; CHF-1512; CNP-1512 |
Approved |
Chiesi Farmaceutici SPA |
Sirio |
Italy |
Parkinson Disease |
null |
2003-01-01 |
Parkinson Disease |
Details
|